LMNL(LMNL)

$8.50—

LMNL(LMNL)

NASDAQ

$8.50—

LMNL(LMNL)

LMNL

LMNL 10 articles

Liminal BioSciences stock rockets on take-private deal with a fund managed by Thomvest Asset Management

Liminal Biosciences' stock soars 91% after getting takeover offer that's more than double its price

Liminal BioSciences Reports Second Quarter 2022 Financial Results and Business Highlights

Liminal BioSciences Pauses Development Of Fezagepras, Outlines R&D Priorities For 2022

LMNL Stock Price Increases Over 93% Intraday: Why It Happened

Liminal BioSciences Stock Is Trading Higher On Sale Of Priority Review Voucher For $105M

LMNL Stock Price: Over 40% Increase Pre-Market Explanation

Liminal BioSciences Stock Falls on Scrapping Further Development of Fezagepras

Liminal BioSciences To Offload Plasma Collection and Plasma-Derived Therapeutics Business To Kedrion

Liminal Biosciences Reports Fourth Quarter and 2019 Year End Results

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance